Xentria, Inc. (Xentria), a clinical-stage biotherapeutics company focused on advancing drug development to address unmet medical needs, today announced it has entered into an exclusive license ...
Promising New Gene Therapy Approach for Genetic Heart Disease: Clinical Trials Imminent Dec. 7, 2023 — Researchers have laid the foundation for the development of a gene therapy for the genetic ...